IBDEI0NL ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10499,1,4,0)
 ;;=4^C69.41
 ;;^UTILITY(U,$J,358.3,10499,2)
 ;;=^5001279
 ;;^UTILITY(U,$J,358.3,10500,0)
 ;;=C69.42^^74^681^34
 ;;^UTILITY(U,$J,358.3,10500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10500,1,3,0)
 ;;=3^Malig Neopl of Ciliary Body,Left Eye
 ;;^UTILITY(U,$J,358.3,10500,1,4,0)
 ;;=4^C69.42
 ;;^UTILITY(U,$J,358.3,10500,2)
 ;;=^5001280
 ;;^UTILITY(U,$J,358.3,10501,0)
 ;;=H35.061^^74^681^35
 ;;^UTILITY(U,$J,358.3,10501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10501,1,3,0)
 ;;=3^Retinal Vasculitis,Right Eye
 ;;^UTILITY(U,$J,358.3,10501,1,4,0)
 ;;=4^H35.061
 ;;^UTILITY(U,$J,358.3,10501,2)
 ;;=^5005602
 ;;^UTILITY(U,$J,358.3,10502,0)
 ;;=H35.062^^74^681^36
 ;;^UTILITY(U,$J,358.3,10502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10502,1,3,0)
 ;;=3^Retinal Vasculitis,Left Eye
 ;;^UTILITY(U,$J,358.3,10502,1,4,0)
 ;;=4^H35.062
 ;;^UTILITY(U,$J,358.3,10502,2)
 ;;=^5005603
 ;;^UTILITY(U,$J,358.3,10503,0)
 ;;=H20.011^^74^681^2
 ;;^UTILITY(U,$J,358.3,10503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10503,1,3,0)
 ;;=3^Iridocyclitis,Primary,Right Eye
 ;;^UTILITY(U,$J,358.3,10503,1,4,0)
 ;;=4^H20.011
 ;;^UTILITY(U,$J,358.3,10503,2)
 ;;=^5005134
 ;;^UTILITY(U,$J,358.3,10504,0)
 ;;=H20.012^^74^681^3
 ;;^UTILITY(U,$J,358.3,10504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10504,1,3,0)
 ;;=3^Iridocyclitis,Primary,Left Eye
 ;;^UTILITY(U,$J,358.3,10504,1,4,0)
 ;;=4^H20.012
 ;;^UTILITY(U,$J,358.3,10504,2)
 ;;=^5005135
 ;;^UTILITY(U,$J,358.3,10505,0)
 ;;=H20.11^^74^681^4
 ;;^UTILITY(U,$J,358.3,10505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10505,1,3,0)
 ;;=3^Iridocyclitis,Chronic,Right Eye
 ;;^UTILITY(U,$J,358.3,10505,1,4,0)
 ;;=4^H20.11
 ;;^UTILITY(U,$J,358.3,10505,2)
 ;;=^5005155
 ;;^UTILITY(U,$J,358.3,10506,0)
 ;;=H20.12^^74^681^5
 ;;^UTILITY(U,$J,358.3,10506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10506,1,3,0)
 ;;=3^Iridocyclitis,Chronic,Left Eye
 ;;^UTILITY(U,$J,358.3,10506,1,4,0)
 ;;=4^H20.12
 ;;^UTILITY(U,$J,358.3,10506,2)
 ;;=^5005156
 ;;^UTILITY(U,$J,358.3,10507,0)
 ;;=H21.551^^74^681^16
 ;;^UTILITY(U,$J,358.3,10507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10507,1,3,0)
 ;;=3^Angle Recession,Right Eye
 ;;^UTILITY(U,$J,358.3,10507,1,4,0)
 ;;=4^H21.551
 ;;^UTILITY(U,$J,358.3,10507,2)
 ;;=^5005255
 ;;^UTILITY(U,$J,358.3,10508,0)
 ;;=H21.552^^74^681^17
 ;;^UTILITY(U,$J,358.3,10508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10508,1,3,0)
 ;;=3^Angle Recession,Left Eye
 ;;^UTILITY(U,$J,358.3,10508,1,4,0)
 ;;=4^H21.552
 ;;^UTILITY(U,$J,358.3,10508,2)
 ;;=^5005256
 ;;^UTILITY(U,$J,358.3,10509,0)
 ;;=H20.041^^74^681^22
 ;;^UTILITY(U,$J,358.3,10509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10509,1,3,0)
 ;;=3^Iridocyclitis,Traumatic,Right Eye
 ;;^UTILITY(U,$J,358.3,10509,1,4,0)
 ;;=4^H20.041
 ;;^UTILITY(U,$J,358.3,10509,2)
 ;;=^5005146
 ;;^UTILITY(U,$J,358.3,10510,0)
 ;;=H20.042^^74^681^23
 ;;^UTILITY(U,$J,358.3,10510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10510,1,3,0)
 ;;=3^Iridocyclitis,Traumatic,Left Eye
 ;;^UTILITY(U,$J,358.3,10510,1,4,0)
 ;;=4^H20.042
 ;;^UTILITY(U,$J,358.3,10510,2)
 ;;=^5005147
 ;;^UTILITY(U,$J,358.3,10511,0)
 ;;=H21.1X1^^74^681^37
 ;;^UTILITY(U,$J,358.3,10511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10511,1,3,0)
 ;;=3^Vascular Disorders of Iris & Ciliary Body,Rt Eye
 ;;^UTILITY(U,$J,358.3,10511,1,4,0)
 ;;=4^H21.1X1
 ;;^UTILITY(U,$J,358.3,10511,2)
 ;;=^5005175
